$INFU
InfuSystem Holdings, Inc

2016 Q2 Form 10-Q Financial Statement

#000119312516677572 Filed on August 10, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $18.12M $16.94M
YoY Change 6.98% 3.47%
Cost Of Revenue $4.789M $4.760M
YoY Change 0.61% 63.41%
Gross Profit $11.14M $12.18M
YoY Change -8.51% 2.16%
Gross Profit Margin 61.49% 71.9%
Selling, General & Admin $8.716M $9.720M
YoY Change -10.33% 29.22%
% of Gross Profit 78.22% 79.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.120M $810.0K
YoY Change 38.27% 710.0%
% of Gross Profit 10.05% 6.65%
Operating Expenses $10.71M $10.53M
YoY Change 1.66% 9.86%
Operating Profit $438.0K $1.650M
YoY Change -73.45% -29.43%
Interest Expense $327.0K -$390.0K
YoY Change -183.85% -150.26%
% of Operating Profit 74.66% -23.64%
Other Income/Expense, Net -$320.0K $0.00
YoY Change -100.0%
Pretax Income $118.0K $700.0K
YoY Change -83.14% -56.3%
Income Tax -$35.00K $60.00K
% Of Pretax Income -29.66% 8.57%
Net Earnings $153.0K $640.0K
YoY Change -76.09% -27.77%
Net Earnings / Revenue 0.84% 3.78%
Basic Earnings Per Share $0.01
Diluted Earnings Per Share $0.01 $27.18K
COMMON SHARES
Basic Shares Outstanding 22.62M shares 22.36M shares
Diluted Shares Outstanding 23.11M shares

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $800.0K $800.0K
YoY Change 0.0% -20.0%
Cash & Equivalents $805.0K $791.0K
Short-Term Investments
Other Short-Term Assets $1.207M $1.044M
YoY Change 15.61% 46.63%
Inventory $2.096M $1.898M
Prepaid Expenses
Receivables $16.95M $12.30M
Other Receivables $0.00 $0.00
Total Short-Term Assets $23.80M $18.29M
YoY Change 30.15% 12.19%
LONG-TERM ASSETS
Property, Plant & Equipment $2.236M $2.390M
YoY Change -6.44% 51.55%
Goodwill $3.585M
YoY Change
Intangibles $31.86M $26.58M
YoY Change 19.83% 9.46%
Long-Term Investments
YoY Change
Other Assets $222.0K $224.0K
YoY Change -0.89% -9.68%
Total Long-Term Assets $76.46M $73.49M
YoY Change 4.05% 19.63%
TOTAL ASSETS
Total Short-Term Assets $23.80M $18.29M
Total Long-Term Assets $76.46M $73.49M
Total Assets $100.3M $91.78M
YoY Change 9.25% 18.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.346M $6.306M
YoY Change -15.22% 53.77%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.939M $6.744M
YoY Change -11.94% 74.22%
Total Short-Term Liabilities $13.85M $16.24M
YoY Change -14.74% 53.99%
LONG-TERM LIABILITIES
Long-Term Debt $33.48M $28.03M
YoY Change 19.44% 22.8%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $33.48M $28.03M
YoY Change 19.44% 22.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.85M $16.24M
Total Long-Term Liabilities $33.48M $28.03M
Total Liabilities $47.33M $44.27M
YoY Change 6.9% 32.65%
SHAREHOLDERS EQUITY
Retained Earnings -$38.74M -$43.34M
YoY Change -10.6% -4.95%
Common Stock $2.000K $2.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $52.94M $47.51M
YoY Change
Total Liabilities & Shareholders Equity $100.3M $91.78M
YoY Change 9.25% 18.07%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income $153.0K $640.0K
YoY Change -76.09% -27.77%
Depreciation, Depletion And Amortization $1.120M $810.0K
YoY Change 38.27% 710.0%
Cash From Operating Activities $1.530M $5.180M
YoY Change -70.46% 111.43%
INVESTING ACTIVITIES
Capital Expenditures -$3.920M -$5.800M
YoY Change -32.41% -1260.0%
Acquisitions
YoY Change
Other Investing Activities $950.0K -$3.030M
YoY Change -131.35% -209.78%
Cash From Investing Activities -$2.970M -$8.830M
YoY Change -66.36% 1258.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.680M 1.220M
YoY Change 37.7% -197.6%
NET CHANGE
Cash From Operating Activities 1.530M 5.180M
Cash From Investing Activities -2.970M -8.830M
Cash From Financing Activities 1.680M 1.220M
Net Change In Cash 240.0K -2.430M
YoY Change -109.88% -541.82%
FREE CASH FLOW
Cash From Operating Activities $1.530M $5.180M
Capital Expenditures -$3.920M -$5.800M
Free Cash Flow $5.450M $10.98M
YoY Change -50.36% 463.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22633972 shares
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
791000
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22623987 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22821647 shares
CY2016Q2 us-gaap Assets
Assets
100267000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
6018000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
6383000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
23804000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4485000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
805000
CY2016Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
10821000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4150000
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16953000
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
2000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3318000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5346000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
7396000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2590000
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91681000
CY2016Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2743000
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2016Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
33482000
CY2016Q2 us-gaap Long Term Debt
LongTermDebt
39421000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
5131000
CY2016Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
5939000
CY2016Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1207000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
18517000
CY2016Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
31855000
CY2016Q2 us-gaap Inventory Net
InventoryNet
2096000
CY2016Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2560000
CY2016Q2 us-gaap Liabilities
Liabilities
47327000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
100267000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
13845000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6358000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2087000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
7328000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
222000
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
52038000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2236000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
52940000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38743000
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
118000
CY2016Q2 infu Unamortized Debt Issuance Expense Current
UnamortizedDebtIssuanceExpenseCurrent
0
CY2016Q2 infu Medical Equipment Net
MedicalEquipmentNet
31329000
CY2016Q2 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
394000
CY2016Q2 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
20183000
CY2016Q2 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
58268000
CY2016Q2 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
1524000
CY2016Q2 infu Unamortized Debt Issuance Expense Noncurrent
UnamortizedDebtIssuanceExpenseNoncurrent
118000
CY2016Q2 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
28069000
CY2016Q2 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
29805000
CY2016Q2 infu Unamortized Value Of Debt Issuance Costs Principal In Year Five
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFive
8000
CY2016Q2 infu Unamortized Value Of Debt Issuance Costs Principal In Year Four
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearFour
31000
CY2016Q2 infu Unamortized Value Of Debt Issuance Costs Principal Remainder Of Fiscal Year
UnamortizedValueOfDebtIssuanceCostsPrincipalRemainderOfFiscalYear
17000
CY2016Q2 infu Unamortized Value Of Debt Issuance Costs Principal In Year Three
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearThree
31000
CY2016Q2 infu Unamortized Value Of Debt Issuance Costs Principal In Year Two
UnamortizedValueOfDebtIssuanceCostsPrincipalInYearTwo
31000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
515000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22541890 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22739550 shares
CY2015Q4 us-gaap Assets
Assets
96315000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
20544000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4737000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
818000
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
11502000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14206000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6586000
us-gaap Net Income Loss
NetIncomeLoss
368000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2337000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91238000
CY2015Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2743000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29750000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
34810000
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5060000
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
861000
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
31534000
CY2015Q4 us-gaap Inventory Net
InventoryNet
1916000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3641000
CY2015Q4 us-gaap Liabilities
Liabilities
45037000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
96315000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15287000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
251000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
51317000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2370000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
51278000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39962000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
134000
CY2015Q4 infu Unamortized Debt Issuance Expense Current
UnamortizedDebtIssuanceExpenseCurrent
0
CY2015Q4 infu Medical Equipment Net
MedicalEquipmentNet
30114000
CY2015Q4 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
232000
CY2015Q4 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
19783000
CY2015Q4 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
53681000
CY2015Q4 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
2277000
CY2015Q4 infu Unamortized Debt Issuance Expense Noncurrent
UnamortizedDebtIssuanceExpenseNoncurrent
134000
CY2015Q4 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
25612000
CY2015Q4 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
27837000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
276000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11969000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1344000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
200000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.397 pure
us-gaap Sales Revenue Net
SalesRevenueNet
33895000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
51546000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2639000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000
us-gaap Gross Profit
GrossProfit
23943000
us-gaap Operating Expenses
OperatingExpenses
21074000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
118000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
230000
us-gaap Interest Expense
InterestExpense
1059000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-11384000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
157000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
3786000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1599000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1876000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
48000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
398639 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
2869000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
30755000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
7873000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
9474000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-138000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3787000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6671000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3140000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22743948 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22345309 shares
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5424000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
43586000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
3281000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
2100000
dei Entity Registrant Name
EntityRegistrantName
InfuSystem Holdings, Inc
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001337013
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-13000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13061000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1834000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
300000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.372 pure
us-gaap Sales Revenue Net
SalesRevenueNet
38110000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
32575000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-605000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27000
us-gaap Gross Profit
GrossProfit
25393000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23069900 shares
us-gaap Operating Expenses
OperatingExpenses
22848000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
126000
us-gaap Net Income Loss
NetIncomeLoss
1219000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2814000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1940000
us-gaap Interest Expense
InterestExpense
632000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5360000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1827000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
33000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
485438 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
2545000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
34423000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3478000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7187000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
721000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1869000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8295000
us-gaap Reductions In Other Assets Amount
ReductionsInOtherAssetsAmount
100000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3687000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22584462 shares
dei Trading Symbol
TradingSymbol
INFU
infu Reduction In Long Term Debt
ReductionInLongTermDebt
100000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
3100000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5139000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
29190000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
4422000
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6392000
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
922000
CY2016Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
100000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
19066000
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-320000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
713000
CY2016Q2 us-gaap Gross Profit
GrossProfit
12086000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
10705000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
724000
CY2016Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1067000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1061000
CY2016Q2 us-gaap Interest Expense
InterestExpense
327000
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
489484 shares
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1381000
CY2016Q2 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
17185000
CY2016Q2 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
300000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
337000
CY2016Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4789000
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1881000
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23109870 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22620386 shares
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2324000
CY2016Q2 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
2191000
CY2016Q2 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1600000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5994000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
100000
us-gaap Sales Revenue Net
SalesRevenueNet
17170000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-387000
us-gaap Gross Profit
GrossProfit
11854000
us-gaap Operating Expenses
OperatingExpenses
10537000
us-gaap Net Income Loss
NetIncomeLoss
783000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1143000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
930000
us-gaap Interest Expense
InterestExpense
387000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
443478 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
1317000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
15616000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
147000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3656000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1554000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22824965 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22381487 shares
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2687000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1660000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1100000

Files In Submission

Name View Source Status
0001193125-16-677572-index-headers.html Edgar Link pending
0001193125-16-677572-index.html Edgar Link pending
0001193125-16-677572.txt Edgar Link pending
0001193125-16-677572-xbrl.zip Edgar Link pending
d230695d10q.htm Edgar Link pending
d230695dex311.htm Edgar Link pending
d230695dex312.htm Edgar Link pending
d230695dex321.htm Edgar Link pending
d230695dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g230695g80v46.jpg Edgar Link pending
infu-20160630.xml Edgar Link completed
infu-20160630.xsd Edgar Link pending
infu-20160630_cal.xml Edgar Link unprocessable
infu-20160630_def.xml Edgar Link unprocessable
infu-20160630_lab.xml Edgar Link unprocessable
infu-20160630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending